Nebivolol Hydrochloride Amarox (Nebivolol Hydrochloride)

Nebivolol Hydrochloride is a selective β1‑blocker used in the management of high‑blood‑pressure disorders.

• Primary hypertension: reduces systolic and diastolic pressure in patients with essential hypertension.
• Essential hypertension: provides long‑term blood‑pressure control in adults.
• Isolated systolic hypertension: helps lower elevated systolic readings in elderly patients.

• Nebivolol Hydrochloride selectively antagonizes β1‑adrenergic receptors in cardiac tissue, decreasing heart rate and myocardial contractility. Concurrently, it stimulates endothelial nitric oxide synthase, enhancing nitric oxide release and causing vasodilation. The combined effect reduces systemic vascular resistance and arterial pressure, contributing to its antihypertensive action.

Nebivolol Hydrochloride may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Headache: mild to moderate intensity.
• Dizziness: often related to blood‑pressure lowering.
• Fatigue: general tiredness or reduced energy.
• Nausea: occasional stomach upset.
• Bradycardia: slower than normal heart rate.
• Peripheral edema: mild swelling of ankles or feet.

Serious or Rare Side Effects

• Severe bradycardia: markedly low heart rate requiring medical attention.
• Symptomatic hypotension: sudden drop in blood pressure causing faintness.
• Allergic reaction: rash, itching, or swelling of face and throat.
• Hepatic injury: abnormal liver function tests.
• Heart block: impaired electrical conduction in the heart.
• Acute bronchospasm: difficulty breathing, especially in asthmatic patients.

Before initiating therapy, clinicians should consider several safety factors.

• Renal impairment: monitor kidney function and adjust therapy as needed.
• Asthma or chronic obstructive pulmonary disease: use with caution as β‑blockade may worsen bronchospasm.
• Diabetes mellitus: may mask hypoglycaemia symptoms; monitor blood glucose closely.
• Concomitant use of other antihypertensives: risk of additive blood‑pressure lowering.
• Pregnancy: safety not established; avoid unless benefits outweigh risks.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Nebivolol Hydrochloride can interact with several drug classes, influencing its safety profile.

Major Interactions (Avoid)

• Non‑selective beta‑blockers: additive bradycardia and hypotension.
• Calcium‑channel blockers (verapamil, diltiazem): increased risk of AV‑block.
• Clonidine: abrupt discontinuation may cause rebound hypertension.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: may enhance hypotensive effect.
• Diuretics: can increase risk of electrolyte disturbances.
• SSRIs or other antidepressants: may affect heart‑rate regulation.